Marie-Christine Chartier-Harlin

8PUBLICATIONS
42CO-AUTHORS
Molecular targetsPharmacogenomicsHaematological tumoursLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 29, 2026
Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson's disease.

Duc Tung Vu, William Sibran, Andreas Metousis

|Jan 09, 2024
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells.

Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka

|Feb 07, 2023
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkers.

Jean-Marc Taymans, Eugénie Mutez, William Sibran

|Nov 26, 2022
Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative Disorders.

Pasquale Sileo, Clémence Simonin, Patricia Melnyk

|Jun 16, 2022
Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease.

Ilda Coku, Eugénie Mutez, Sabiha Eddarkaoui

|Mar 25, 2022
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively.

Antoine Marchand, Alessia Sarchione, Panagiotis S Athanasopoulos

Pageof 2

Frequent Collaborators

6 joint publications

Jean-Marc Taymans

3 joint publications

Liesel Goveas

2 joint publications

Xavier Thuru

2 joint publications

Antoine Marchand